[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
July 2, 2003

Medicare Bill Uncertain

JAMA. 2003;290(1):29. doi:10.1001/jama.290.1.29-a
Generics Get Boost

Tactics used by drug companies to extend patent rights would be barred under legislation approved by the Senate Health, Education, Labor, and Pensions Committee. If passed, the bill would save consumers an estimated $60 billion over the next decade by speeding generic alternatives to market, according to a report from the Federal Trade Commission.

Generics Get Boost

Ranking Sen Edward Kennedy (D, Mass) pushed for the measure, arguing that large drug makers have been exploiting loopholes in current patent law. Committee Chairman Judd Gregg (R, NH) and Sen Charles Schumer (D, NY) issued a statement blasting the drug industry for stifling competition with frivolous lawsuits and questionable payoffs to generic manufacturers.

First Page Preview View Large
First page PDF preview
First page PDF preview
×